lupus.org - In Japan, new research finds that use of the antimalarial drug hydroxychloroquine (HCQ), also known by the brand name Plaquenil, is not associated with short-term risk of hospitalized infection (HI).…
Japanese Data Show Use of Hydroxychloroquine is Not Associated with Hospitalized Infections #HCQnews
